Clinical Trials on Subjects With Hyperuricemia in United States
Total 3170 results
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal or With Ocular PathologyUnited States
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal EyesUnited States
-
Medtronic - MITGCompletedSubjects With an Existing Intra-arterial LineUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With no Known Ocular DiseasesUnited States
-
TakedaCompletedJoint DamageUnited States
-
Rempex Pharmaceuticals (a wholly owned subsidiary...CompletedSubjects With Varying Degrees of Renal Insufficiency and | Subjects With Normal Renal FunctionUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
University of MinnesotaCompleted
-
AstraZenecaContract Research Organization: USA; PAREXEL Early Phase Clinical Unit Baltimore and other collaboratorsCompletedAsymptomatic HyperuricemiaUnited States
-
University of PennsylvaniaCompletedSubjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)United States
-
University of Missouri-ColumbiaWithdrawn
-
Ventrus Biosciences, IncUnknownAdult Subjects With Anal Fissures.United States
-
Washington D.C. Veterans Affairs Medical CenterAstraZeneca; Howard UniversityUnknown
-
DeNova ResearchCompletedSubjects Requesting and Requiring Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid FillersUnited States
-
Ahmad SlimGlaxoSmithKlineTerminatedHypertriglyceridemia in Type 4 Hyperlipidemia | Non Diabetic Subjects With NormoglycemiaUnited States
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
Savient PharmaceuticalsCompletedGoutUnited States, Canada, Mexico
-
DexCom, Inc.CompletedPediatric Subjects With Diabetes MellitusUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedSubjects With Severe, Refractory Sclerotic Skin ChangesUnited States
-
University of Mississippi Medical CenterU.S. Highbush Blueberry CouncilCompleted
-
Dizal PharmaceuticalsRecruitingHealthy SubjectsUnited States
-
Indiana UniversityPurdue UniversityRecruiting
-
KBP BiosciencesParexelCompleted
-
Chrysea Labs LdaActive, not recruiting
-
BioLineRx, Ltd.CelerionCompletedHealthy SubjectsUnited States
-
Oyster Point Pharma, Inc.CompletedHealthy SubjectsUnited States
-
Theravance BiopharmaCompleted
-
Astellas Pharma Global Development, Inc.Completed
-
Clinical Nutrition Research Center, Illinois Institute...CompletedHealthy SubjectsUnited States
-
Cortendo ABCompleted
-
Vance Fowler, M.D.National Institute of Allergy and Infectious Diseases (NIAID)CompletedHealthy SubjectsUnited States
-
Procter and GambleCompletedHealthy SubjectsUnited States
-
Rempex Pharmaceuticals (a wholly owned subsidiary...Completed
-
University of MinnesotaCompleted
-
Trius Therapeutics LLCCompleted
-
Spaulding Rehabilitation HospitalCompleted
-
ViiV HealthcareCompleted
-
Eisai Inc.CompletedHealthy SubjectsUnited States
-
Eisai Inc.CompletedHealthy SubjectsUnited States
-
GlaxoSmithKlineCompletedHealthy SubjectsUnited States
-
Medtronic - MITGCompleted
-
Medtronic - MITGCompleted
-
Corcept TherapeuticsCompletedHealthy SubjectsUnited States
-
GlaxoSmithKlineCompletedHealthy SubjectsUnited States
-
Temple UniversityCompleted
-
SirnaomicsMedpace, Inc.Completed
-
Dizal PharmaceuticalsCompletedHealthy SubjectsUnited States
-
Idorsia Pharmaceuticals Ltd.Janssen Biotech, Inc.Completed